Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3516)
All Articles published online
|
Jan 14, 2006 (publication date) through Feb 17, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tang RF, Wang SX, Peng L, Wang SX, Zhang M, Li ZF, Zhang ZM, Xiao Y, Zhang FR. Expression of vascular endothelial growth factors A and C in human pancreatic cancer. World J Gastroenterol 2006; 12(2): 280-286 [PMID: 16482630 DOI: 10.3748/wjg.v12.i2.280] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i2/280.htm |
| Number | Citing Articles |
| 1 |
Chery Whipple, Murray Korc. Targeting angiogenesis in pancreatic cancer: rationale and pitfalls. Langenbeck's Archives of Surgery 2008; 393(6): 901 doi: 10.1007/s00423-008-0280-z
|
| 2 |
Ilse Van der Auwera, Peter B. Vermeulen, Luc Y. Dirix. Lymphangiogenesis in Cancer Metastasis. Cancer Metastasis – Biology and Treatment 2009; 13: 119 doi: 10.1007/978-90-481-2247-9_6
|
| 3 |
M.I. Costache, Mihai Ioana, Sevastiţa Iordache, D. Ene, Cornelia Alexandra Costache, A. Săftoiu. VEGF expression in pancreatic cancer and other malignancies: a review of the literature. Romanian Journal Of Internal Medicine 2015; 53(3): 199 doi: 10.1515/rjim-2015-0027
|
| 4 |
JINGHUI GUO, WENHUI LOU, YUAN JI, SHUNCAI ZHANG. Effect of CCR7, CXCR4 and VEGF-C on the lymph node metastasis of human pancreatic ductal adenocarcinoma. Oncology Letters 2013; 5(5): 1572 doi: 10.3892/ol.2013.1261
|
| 5 |
Syeda Kiran Riaz, Yasmeen Iqbal, Muhammad Faraz Arshad Malik. Diagnostic and Therapeutic Implications of the Vascular Endothelial Growth Factor Family in Cancer. Asian Pacific Journal of Cancer Prevention 2015; 16(5): 1677 doi: 10.7314/APJCP.2015.16.5.1677
|
| 6 |
Babs G. Sibinga Mulder, Marjory Koller, Evelien W. Duiker, Arantza Farina Sarasqueta, Jakobus Burggraaf, Vincent E. de Meijer, Alexander L. Vahrmeijer, Frederik J.H. Hoogwater, Bert A. Bonsing, Gooitzen M. van Dam, J. Sven D. Mieog, Bobby K. Pranger. Intraoperative Molecular Fluorescence Imaging of Pancreatic Cancer by Targeting Vascular Endothelial Growth Factor: A Multicenter Feasibility Dose-Escalation Study. Journal of Nuclear Medicine 2023; 64(1): 82 doi: 10.2967/jnumed.121.263773
|
| 7 |
Wei Lan, Zhentao Tang, Haibo Liao, Qingfeng Chen, Yi-Ping Phoebe Chen, Zhaolei Zhang, Jianxin Wang. MULGONET: An interpretable neural network framework to integrate multi-omics data for cancer recurrence prediction and biomarker discovery. Fundamental Research 2025; doi: 10.1016/j.fmre.2025.01.004
|
| 8 |
Ursula Aho, Xia Zhao, Matthias Löhr, Roland Andersson. Molecular mechanisms of pancreatic cancer and potential targets of treatment. Scandinavian Journal of Gastroenterology 2007; 42(3): 279 doi: 10.1080/00365520601106384
|
| 9 |
Yosuke Doi, Masakazu Yashiro, Nobuya Yamada, Ryosuke Amano, Go Ohira, Masahiro Komoto, Satoru Noda, Shinichiro Kashiwagi, Yukihiro Kato, Yuhiko Fuyuhiro, Kosei Hirakawa. Significance of phospho‐vascular endothelial growth factor receptor‐2 expression in pancreatic cancer. Cancer Science 2010; 101(6): 1529 doi: 10.1111/j.1349-7006.2010.01547.x
|
| 10 |
H. Oettle, U. Pelzer, J. Stieler, H. Riess. Adjuvante und palliative Therapie des Pankreaskarzinoms. Der Onkologe 2010; 16(6): 595 doi: 10.1007/s00761-010-1851-5
|
| 11 |
Mayank Kashyap, Saurabh Gupta, Yogita Bansal, Gulshan Bansal. A critical analysis of design, binding pattern and SAR of benzo-fused heteronuclear compounds as VEGFR-2 inhibitors. Bioorganic & Medicinal Chemistry 2024; 115: 117966 doi: 10.1016/j.bmc.2024.117966
|
| 12 |
Yuki Hattori, Toshifumi Gabata, Osamu Matsui, Kentaro Mochizuki, Hirohisa Kitagawa, Masato Kayahara, Tetsuo Ohta, Yasuni Nakanuma. Enhancement patterns of pancreatic adenocarcinoma on conventional dynamic multi-detector row CT: Correlation with angiogenesis and fibrosis. World Journal of Gastroenterology 2009; 15(25): 3114-3121 doi: 10.3748/wjg.15.3114
|
| 13 |
Sabrina Höbel, Ivette Koburger, Matthias John, Frank Czubayko, Philipp Hadwiger, Hans‐Peter Vornlocher, Achim Aigner. Polyethylenimine/small interfering RNA‐mediated knockdown of vascular endothelial growth factor in vivo exerts anti‐tumor effects synergistically with Bevacizumab. The Journal of Gene Medicine 2010; 12(3): 287 doi: 10.1002/jgm.1431
|
| 14 |
R A Smith, J Tang, C Tudur-Smith, J P Neoptolemos, P Ghaneh. Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer. British Journal of Cancer 2011; 104(9): 1440 doi: 10.1038/bjc.2011.110
|
| 15 |
Kyu-Shik Lee, Jin-Sun Shin, Kyung-Soo Nam, Yun-Hee Shon. Anti-angiogenic activity in metastasis of human breast cancer cells irradiated by a proton beam. Journal of the Korean Physical Society 2012; 61(2): 268 doi: 10.3938/jkps.61.268
|
| 16 |
Zhiwen Xiao, Guopei Luo, Chen Liu, Chuntao Wu, Liang Liu, Zuqiang Liu, Quanxing Ni, Jiang Long, Xianjun Yu. Molecular Mechanism Underlying Lymphatic Metastasis in Pancreatic Cancer. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/925845
|
| 17 |
Hendrik Seeliger, Peter Camaj, Ivan Ischenko, Axel Kleespies, Enrico N. De Toni, Susanne E. Thieme, Helmut Blum, Gerald Assmann, Karl-Walter Jauch, Christiane J. Bruns.
EFEMP1 Expression Promotes In vivo Tumor Growth in Human Pancreatic Adenocarcinoma. Molecular Cancer Research 2009; 7(2): 189 doi: 10.1158/1541-7786.MCR-08-0132
|
| 18 |
Katherine T. Ostapoff, Michael T. Dellinger, Niranjan Awasthi, Rolf A. Brekken, Roderich E. Schwarz. Experimental Metastasis: Modeling and Analysis. 2013; : 57 doi: 10.1007/978-94-007-7835-1_4
|
| 19 |
Daniel Borja-Cacho, Eric Hans Jensen, Ashok Kumar Saluja, Donald J. Buchsbaum, Selwyn Maurice Vickers. Molecular targeted therapies for pancreatic cancer. The American Journal of Surgery 2008; 196(3): 430 doi: 10.1016/j.amjsurg.2008.04.009
|
| 20 |
D Ansari, A Rosendahl, J Elebro, R Andersson. Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer. British Journal of Surgery 2011; 98(8): 1041 doi: 10.1002/bjs.7574
|
| 21 |
Bhaskar Venkata Kameswara Subrahmanya Lakkakula, Batoul Farran, Saikrishna Lakkakula, Sujatha Peela, Nagendra Sastry Yarla, Pallaval Veera Bramhachari, Mohammad Amjad Kamal, Madhu Sudhana Saddala, Ganji Purnachandra Nagaraju. Small molecule tyrosine kinase inhibitors and pancreatic cancer—Trials and troubles. Seminars in Cancer Biology 2019; 56: 149 doi: 10.1016/j.semcancer.2018.09.011
|
| 22 |
Xiaohui Zhao, Yimin Liu, Zhihua Li, Shangyou Zheng, Zairui Wang, Wenzhu Li, Zhuofei Bi, Liting Li, Yanhui Jiang, Yuming Luo, Qing Lin, Zhiqiang Fu, Chen Rufu. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa‐miR‐29b‐3p in pancreatic ductal adenocarcinoma. Journal of Cellular and Molecular Medicine 2018; 22(1): 655 doi: 10.1111/jcmm.13351
|
| 23 |
Peter Camaj, Carsten Jäckel, Stefan Krebs, Enrico N. DeToni, Helmut Blum, Karl-Walter Jauch, Peter J. Nelson, Christiane J. Bruns. Hypoxia-Independent Gene Expression Mediated by SOX9 Promotes Aggressive Pancreatic Tumor Biology. Molecular Cancer Research 2014; 12(3): 421 doi: 10.1158/1541-7786.MCR-13-0351
|
| 24 |
Yosuke Doi, Masakazu Yashiro, Nobuya Yamada, Ryosuke Amano, Satoru Noda, Kosei Hirakawa. VEGF-A/VEGFR-2 Signaling Plays an Important Role for the Motility of Pancreas Cancer Cells. Annals of Surgical Oncology 2012; 19(8): 2733 doi: 10.1245/s10434-011-2181-6
|
| 25 |
Majid Momeny, Zivar Alishahi, Haniyeh Eyvani, Fatemeh Esmaeili, Azam Zaghal, Parisa Ghaffari, Javad Tavakkoly-Bazzaz, Kamran Alimoghaddam, Ardeshir Ghavamzadeh, Seyed H. Ghaffari. Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal adenocarcinoma cells. Cellular Oncology 2020; 43(1): 81 doi: 10.1007/s13402-019-00473-9
|